No longer enrolling
The 4WHIM clinical research study is no longer enrolling. Results of this phase 3 study will determine if the investigational study drug, mavorixafor, helps people with WHIM syndrome by targeting the way the disease works and safely reduces bacterial infections and warts.
Enter your email address to receive updates about the 4WHIM Trial, WHIM syndrome, and X4 Pharmaceuticals news.